<p> Brazil's health regulatory agency said Tuesday it had approved the Pfizer-BioNTech Covid-19 vaccine for widespread use, as the country races to secure enough doses to contain one of the world's worst outbreaks.</p>.<p>"It gives me great pleasure to announce that after a 17-day review, (regulators) have granted the first approval in the Americas for widespread use of a vaccine against Covid-19," said Antonio Barra Torres, the director of federal health regulator Anvisa, underlining that the approval was definitive and not only for emergency use.</p>.<p>However, the vaccine is not yet available in Brazil, which is so far using two others: Chinese-developed CoronaVac and one developed by Oxford University and British-Swedish pharmaceutical firm AstraZeneca.</p>
<p> Brazil's health regulatory agency said Tuesday it had approved the Pfizer-BioNTech Covid-19 vaccine for widespread use, as the country races to secure enough doses to contain one of the world's worst outbreaks.</p>.<p>"It gives me great pleasure to announce that after a 17-day review, (regulators) have granted the first approval in the Americas for widespread use of a vaccine against Covid-19," said Antonio Barra Torres, the director of federal health regulator Anvisa, underlining that the approval was definitive and not only for emergency use.</p>.<p>However, the vaccine is not yet available in Brazil, which is so far using two others: Chinese-developed CoronaVac and one developed by Oxford University and British-Swedish pharmaceutical firm AstraZeneca.</p>